Punjab Chemicals & Crop Protection Ltd
Incorporated in 1975, Punjab Chemicals
& Crop Protection Ltd is in the business
of Performance Chemicals[1]
- Market Cap ₹ 1,692 Cr.
 - Current Price ₹ 1,380
 - High / Low ₹ 1,666 / 662
 - Stock P/E 31.2
 - Book Value ₹ 341
 - Dividend Yield 0.22 %
 - ROCE 14.7 %
 - ROE 11.6 %
 - Face Value ₹ 10.0
 
Pros
Cons
- The company has delivered a poor sales growth of 10.4% over past five years.
 - Dividend payout has been low at 7.35% of profits over last 3 years
 - Debtor days have increased from 78.5 to 102 days.
 
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 416 | 409 | 356 | 411 | 488 | 640 | 548 | 676 | 931 | 1,004 | 931 | 898 | 987 | |
| 381 | 365 | 331 | 405 | 454 | 574 | 506 | 582 | 792 | 882 | 818 | 799 | 883 | |
| Operating Profit | 36 | 44 | 26 | 5 | 34 | 66 | 41 | 94 | 139 | 122 | 112 | 99 | 104 | 
| OPM % | 9% | 11% | 7% | 1% | 7% | 10% | 8% | 14% | 15% | 12% | 12% | 11% | 11% | 
| 13 | 8 | 47 | 29 | 15 | 2 | 19 | 1 | 0 | 4 | 3 | -3 | 6 | |
| Interest | 32 | 32 | 21 | 22 | 18 | 17 | 18 | 12 | 12 | 18 | 19 | 18 | 17 | 
| Depreciation | 15 | 18 | 15 | 14 | 14 | 19 | 15 | 15 | 17 | 19 | 22 | 25 | 26 | 
| Profit before tax | 1 | 4 | 36 | -1 | 17 | 32 | 27 | 68 | 110 | 89 | 74 | 54 | 67 | 
| Tax % | 0% | 0% | 0% | 53% | 40% | 37% | 42% | 26% | 27% | 31% | 26% | 26% | |
| 1 | 4 | 36 | -2 | 10 | 20 | 16 | 51 | 81 | 61 | 54 | 40 | 52 | |
| EPS in Rs | 0.96 | 2.90 | 29.05 | -1.71 | 8.48 | 16.51 | 12.87 | 41.22 | 65.91 | 49.70 | 44.40 | 32.43 | 42.06 | 
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 9% | 12% | 5% | 5% | 6% | 7% | 9% | 
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% | 
| 5 Years: | 10% | 
| 3 Years: | -1% | 
| TTM: | 11% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% | 
| 5 Years: | 22% | 
| 3 Years: | -19% | 
| TTM: | 34% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% | 
| 5 Years: | 17% | 
| 3 Years: | 5% | 
| 1 Year: | 22% | 
| Return on Equity | |
|---|---|
| 10 Years: | 20% | 
| 5 Years: | 22% | 
| 3 Years: | 16% | 
| Last Year: | 12% | 
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 
| Reserves | 7 | 7 | 42 | 60 | 70 | 89 | 102 | 152 | 229 | 286 | 336 | 372 | 406 | 
| 323 | 282 | 170 | 143 | 117 | 91 | 99 | 88 | 93 | 94 | 123 | 168 | 124 | |
| 128 | 119 | 135 | 142 | 169 | 192 | 200 | 219 | 239 | 242 | 197 | 282 | 186 | |
| Total Liabilities | 470 | 420 | 359 | 357 | 368 | 384 | 413 | 470 | 574 | 634 | 669 | 835 | 728 | 
| 234 | 221 | 175 | 169 | 177 | 180 | 168 | 189 | 212 | 222 | 236 | 251 | 257 | |
| CWIP | 1 | 7 | 4 | 6 | 4 | 7 | 15 | 16 | 7 | 20 | 12 | 14 | 14 | 
| Investments | 3 | 4 | 4 | 5 | 1 | 1 | 1 | 1 | 1 | 2 | 8 | 4 | 20 | 
| 232 | 190 | 176 | 177 | 186 | 197 | 230 | 265 | 354 | 390 | 413 | 565 | 437 | |
| Total Assets | 470 | 420 | 359 | 357 | 368 | 384 | 413 | 470 | 574 | 634 | 669 | 835 | 728 | 
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36 | 48 | 81 | 48 | 58 | 69 | 32 | 47 | 32 | 57 | 29 | 23 | |
| -2 | -0 | 12 | -8 | -15 | -21 | -14 | -14 | -27 | -36 | -36 | -28 | |
| -15 | -65 | -97 | -40 | -43 | -4 | -19 | -23 | -9 | -20 | 5 | 12 | |
| Net Cash Flow | 19 | -17 | -5 | 0 | 1 | 45 | 0 | 10 | -4 | 1 | -1 | 7 | 
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 52 | 57 | 43 | 31 | 35 | 32 | 45 | 44 | 52 | 81 | 102 | 
| Inventory Days | 104 | 87 | 82 | 83 | 83 | 75 | 97 | 91 | 99 | 97 | 85 | 151 | 
| Days Payable | 112 | 92 | 101 | 122 | 131 | 103 | 100 | 102 | 84 | 79 | 75 | 136 | 
| Cash Conversion Cycle | 52 | 48 | 38 | 4 | -17 | 7 | 29 | 35 | 58 | 70 | 91 | 117 | 
| Working Capital Days | -84 | -114 | -56 | -51 | -40 | -37 | -13 | 13 | 31 | 45 | 56 | 72 | 
| ROCE % | 11% | 12% | 8% | 10% | 15% | 30% | 22% | 34% | 42% | 29% | 21% | 15% | 
Documents
Announcements
- 
        
          Unaudited (Standalone And Consolidated) Financial Results Of The Company For Quarter And Half Year Ended September 30, 2025
          
            7h - Unaudited standalone/consolidated Q2/H1 results ended 30 Sep 2025; H1 profit Rs3,747 lakh; final dividend Rs3.00.
 - 
        
          Board Meeting Outcome for 0Utcome Of Board Meeting
          
            13h - Unaudited Q2/H1 results approved Nov 3, 2025; H1 standalone profit Rs.3,747 lakh; Rs.3/dividend.
 - 
        
          Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
          
            27 Oct - Of Post Results Conference Call scheduled to be held on Tuesday, November 4, 2025.
 - 
        
          Board Meeting Intimation for Consideration And Approval Of Unaudited (Standalone And Consolidated) Financial Results Of The Company For Quarter And Half Year Ended 30Th September, 2025
          
            7 Oct - Board meeting on Nov 3, 2025 to approve unaudited Q2 and H1 results; trading window closed Oct 1.
 - 
        
          Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
          
            7 Oct - RTA certificate under Reg 74(5) confirming physical share certificates cancelled and dematerialised for quarter ended 30 Sep 2025.
 
Annual reports
- 
    
      Financial Year 2025
      from bse
 - 
    
      Financial Year 2024
      from bse
 - 
    
      Financial Year 2023
      from bse
 - 
    
      Financial Year 2022
      from bse
 - 
    
      Financial Year 2021
      from bse
 - 
    
      Financial Year 2020
      from bse
 - 
    
      Financial Year 2019
      from bse
 - 
    
      Financial Year 2018
      from bse
 - 
    
      Financial Year 2017
      from bse
 - 
    
      Financial Year 2016
      from bse
 - 
    
      Financial Year 2015
      from bse
 - 
    
      Financial Year 2014
      from bse
 - 
    
      Financial Year 2013
      from nse
 - 
    
      Financial Year 2013
      from bse
 - 
    
      Financial Year 2012
      from bse
 
Concalls
- 
      Jul 2025Transcript PPT REC
 - 
      May 2025Transcript PPT REC
 - 
      Jan 2025Transcript PPT
 - 
      Oct 2024Transcript PPT
 - 
      Aug 2024Transcript PPT
 - 
      May 2024Transcript PPT REC
 - 
      Feb 2024Transcript PPT REC
 - 
      Nov 2023Transcript PPT REC
 - 
      Aug 2023Transcript PPT REC
 - 
      May 2023Transcript PPT REC
 - 
      May 2023TranscriptNotesPPT
 - 
      Feb 2023Transcript PPT REC
 - 
      Nov 2022Transcript PPT
 - 
      Aug 2022Transcript PPT
 - 
      May 2022Transcript PPT
 - 
      May 2022TranscriptNotesPPT
 - 
      Feb 2022Transcript PPT
 - 
      Nov 2021Transcript PPT
 - 
      Aug 2021Transcript PPT
 - 
      Jun 2021TranscriptNotesPPT
 - 
      Jan 2021TranscriptNotesPPT
 - 
      Nov 2020TranscriptNotesPPT
 
Business Overview:[1]
PCCPL operates in Agrochemicals, Pharmaceuticals, and Industrial Chemicals, offering Contract Research and Manufacturing Services (CRAMS) with a focus on innovation.